Real-World data sought on ibalizumab for Tough-to-Treat HIV

NCT ID NCT05388474

Completed Disease control Sponsor: Theratechnologies Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study looks at how well the drug ibalizumab works for people with multidrug-resistant HIV in everyday medical practice. It compares patients who receive ibalizumab plus other HIV drugs to similar patients who do not receive ibalizumab. The goal is to understand long-term virus control, immune system health, and safety. About 168 heavily treatment-experienced adults with limited options are being followed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS MULTI-ANTIVIRAL RESISTANCE

Contacts and locations

Locations

Aids Healthcare Foundation

Fort Lauderdale, Florida, 33308, United States
Amity Medical Group

Charlotte, North Carolina, 28215, United States
BIOS Clinical Research

Palm Springs, California, 92262, United States
Bliss Health

Orlando, Florida, 32806, United States
Boston Medical Center

Boston, Massachusetts, 02118, United States
CAN Community Health

Tampa, Florida, 34232, United States
Can Community Health

Tampa, Florida, 33614, United States
Circle Care Center

Stamford, Connecticut, 06850, United States
Gary J. Richmond, M.D., PA

Fort Lauderdale, Florida, 33316, United States
Georgetown University Medical Center

Washington D.C., District of Columbia, 20007, United States
Henry Ford Hospital

Detroit, Michigan, 48202, United States
I.D. Care Associates, PA

Hillsborough, New Jersey, 08844, United States
Indiana University Health Inc.

Bloomington, Indiana, 47405, United States
Las Vegas Research Center

Las Vegas, Nevada, 89106, United States
Legacy Community Pharmacy Services

Houston, Texas, 77074, United States
Medical University of South Carolina

Charleston, South Carolina, 29425, United States
Midway Specialty Care Center Miami Beach

Miami Beach, Florida, 33140, United States
Mills Clinical Research

Los Angeles, California, 90046, United States
North Texas Infectious Diseases Consultants, P.A

Dallas, Texas, 75246, United States
Orlando Immunology Center (OIC)

Orlando, Florida, 32803, United States
Prime Healthcare Services - St Michael's Medical Center

Newark, New Jersey, 07102, United States
Prism Health North Texas

Dallas, Texas, 75204, United States
Ruane Clinical Research

Los Angeles, California, 90036, United States
SUNY Upstate Medical Center

Syracuse, New York, 13210, United States
St-Joseph's Comprehensive Research

Tampa, Florida, 33614, United States
St. Hope Foundation

Houston, Texas, 77036, United States
The Research Institute

Springfield, Massachusetts, 01105, United States
The Roper St. Francis Ryan White Wellness Center

Charleston, South Carolina, 29407, United States
Therapeutic Concepts, PA

Houston, Texas, 77004, United States
Triple O Research Institute PA

West Palm Beach, Florida, 33407, United States
UC San Diego Owen Clinic

San Diego, California, 92103, United States
UT Health Houston

Houston, Texas, 77030, United States
University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States
Waterbury Hospital

Waterbury, Connecticut, 06702, United States
Whitman Walker Health

Washington D.C., District of Columbia, 20005, United States
Yale University

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.